Balchem Corporation (NASDAQ:BCPC) Holdings Raised by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. boosted its stake in Balchem Corporation (NASDAQ:BCPC - Free Report) by 243.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,390 shares of the basic materials company's stock after buying an additional 6,654 shares during the period. Cambridge Investment Research Advisors Inc.'s holdings in Balchem were worth $1,559,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in BCPC. Covestor Ltd grew its stake in shares of Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after purchasing an additional 76 shares in the last quarter. Federated Hermes Inc. bought a new position in shares of Balchem in the fourth quarter worth $33,000. Versant Capital Management Inc grew its stake in shares of Balchem by 534.2% in the first quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company's stock worth $40,000 after purchasing an additional 203 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Balchem by 230.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock worth $106,000 after purchasing an additional 450 shares in the last quarter. Finally, Huntington National Bank grew its stake in shares of Balchem by 30.9% in the fourth quarter. Huntington National Bank now owns 661 shares of the basic materials company's stock worth $108,000 after purchasing an additional 156 shares in the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.

Balchem Price Performance

Shares of Balchem stock traded up $1.72 during trading on Friday, hitting $164.92. The stock had a trading volume of 83,019 shares, compared to its average volume of 143,109. The company has a debt-to-equity ratio of 0.18, a current ratio of 2.44 and a quick ratio of 1.40. The firm has a market cap of $5.38 billion, a P/E ratio of 39.55, a PEG ratio of 3.56 and a beta of 0.89. The business has a fifty day moving average of $163.40 and a two-hundred day moving average of $163.06. Balchem Corporation has a fifty-two week low of $145.70 and a fifty-two week high of $186.03.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.25 by ($0.03). The firm had revenue of $250.52 million during the quarter, compared to analyst estimates of $245.70 million. Balchem had a net margin of 14.16% and a return on equity of 12.01%. The company's quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.03 EPS. On average, sell-side analysts expect that Balchem Corporation will post 4.64 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. HC Wainwright set a $180.00 price target on Balchem and gave the stock a "buy" rating in a research note on Monday, April 28th. Wall Street Zen cut Balchem from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.